Skip to main content
Produced by W2D1 Media. Work with us →

About Vexev

Vexev is a Sydney medtech company founded in 2018 by UNSW PhDs Dr John Carroll and Dr Eamonn Colley. It makes VxWave, a robotic, AI-guided ultrasound system that lets non-specialist staff scan blood vessels in the arm, starting with dialysis patients.

In August 2026 it raised a round to fund FDA 510(k) clearance and a US launch. Investors include Blackbird, Neotribe, Startmate and TEN13.

Sector
Vascular imaging medtech
Business model
Med-tech (robotic imaging hardware + AI)
Founded
2018
Founders
John Carroll, Eamonn Colley
Headquarters
Sydney
Markets
Australia, US
Total raised
$19M (Aug 2026)

Sources: dealroom.co, mobihealthnews.com, startupdaily.net, vexev.com, vexev.com

The people on Day One.

Hear from the team.

Milestones.

  1. Co-founded by John Carroll and Eamonn Colley from UNSW researchseedtable.com
  2. Raised $8.5M led by Neotribe Venturesstartupdaily.net
  3. Raised US$6M for FDA clearance and US commercialisationmobihealthnews.com

In the news.

Backers heard on Day One.

Also backed by Neotribe Ventures, Horizon, Alumni Ventures, Bioshore Ventures.

Sources: dealroom.co

Spot something wrong? Suggest a correctionUpdated 28 October 2026

Be part of
the conversation.

Put your brand alongside the voices founders, investors and operators come to hear.

Explore sponsorship

Want a show like this for your fund or company?

We're W2D1 Media — the team behind the Day One Network, and we helped build Blackbird Ventures' Wild Hearts. We turn podcasts into trust, authority and pipeline.

Book a call →